Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
28.6%
% of ARKG's 30 holdings also in IDNA
17.4%
% of IDNA's 51 holdings also in ARKG
Overlap by Weight
Sector Drift (ARKG minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in ARKG |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
TWIST BIOSCIENCE CORP. | 8.6% | 3.5% | 3.5% |
|
INCYTE CORP | 1.0% | 3.9% | 1.0% |
|
REGENERON PHARMACEUTICALS | 0.8% | 3.7% | 0.8% |
 |
ALCOBRA LTD | 2.5% | 0.5% | 0.5% |
|
PACIFIC BIOSCIENCES OF CALIF | 1.3% | 0.4% | 0.4% |
Position Highlights (Non-Overlapping Exposures)
ARKG Overweight Relative to IDNA
|
CRISPR THERAPEUTICS AG | 7.4% |
|
RECURSION PHARMACEUTICALS, INC CLASS | 7.0% |
|
GUARDANT HEALTH, INC. | 6.3% |
|
NATERA INC | 6.1% |
|
ADAPTIVE BIOTECHNOLOGIES CORP. | 6.1% |
|
SCHRODINGER, INC. | 5.2% |
|
TWIST BIOSCIENCE CORP. | 5.1% |
|
BEAM THERAPEUTICS, INC. | 4.0% |
|
VERACYTE INC | 3.6% |
|
CAREDX, INC. | 3.4% |
ARKG Underweight Relative to IDNA
 |
BEIGENE, LTD. | -5.9% |
 |
SANOFI-AVENTIS | -5.5% |
 |
GSK PLC | -5.4% |
 |
ROCHE HOLDING LTD | -5.4% |
|
EXELIXIS INC | -5.3% |
|
ASTRAZENECA PLC | -5.1% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -5.0% |
|
SPRINGWORKS THERAPEUTICS, INC. | -4.8% |
 |
GENMAB A/S | -4.7% |
 |
BIONTECH SE SPONSORED ADR | -4.1% |